1021 - 1030 of 4301 Drugs
Ca-DTPA (pentetate calcium trisodium inj)
Ca-DTPA (pentetate calcium trisodium) is a chelating agent used to treat patients with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination.
Jevtana (cabazitaxel injection)
Jevtana (cabazitaxel) is a cancer (antineoplastic) medication used together with prednisone to treat prostate cancer that has spread to other parts of the body (metastatic). Jevtana is usually given after other cancer medicines have been tried without success.
Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)
Cabenuva (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension) is a 2-drug co-packaged product of a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI) and an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Dostinex (cabergoline)
Dostinex (cabergoline) is a dopamine receptor antagonist used to treat a hormone imbalance in which there is too much prolactin in the blood (also called hyperprolactinemia).
Cablivi (caplacizumab-yhdp injection)
Cablivi (caplacizumab-yhdp) is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Cabometyx (cabozantinib tablets)
Cabometyx (cabozantinib) Tablets is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy.
Vocabria (cabotegravir tablets for oral use)
Vocabria (cabotegravir) is a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI) indicated in combination with Edurant (rilpivirine) for short-term treatment of HIV-1 infection in adults who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine, for use as oral lead-in to assess the tolerability of cabotegravir prior to administration of Cabenuva (cabotegravir; rilpivirine) extended-release injectable suspensions and for use as oral therapy for patients who will miss planned injection dosing with Cabenuva.
Cometriq (cabozantinib capsules)
Cometriq (cabozantinib) capsules are kinase inhibitors used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body.
Caelyx (pegylated liposomal doxorubicin hydrochloride injection)
Caelyx (pegylated liposomal doxorubicin hydrochloride for injection) is an anthracycline topoisomerase II inhibitor indicated for monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk associated with conventional doxorubicin; advanced ovarian carcinoma in women who have failed standard first-line therapy; AIDS-related Kaposi's sarcoma (KS) in patients with low CD4 counts (less than 200 CD4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease whose disease has progressed despite therapy or who are intolerant to prior systemic combination chemotherapy comprising of at least two of the following agents: a vinca alkaloid, bleomycin and doxorubicin (or another anthracycline). Caelyx is a Canadian brand name for liposomal doxorubicin hydrochloride. A brand name for liposomal doxorubicin hydrochloride in the U.S. is Doxil.
Cafcit (caffeine citrate)
Cafcit (caffeine citrate) is a central nervous system stimulant used to treat breathing problems in premature infants. Cafcit is available in generic form.